Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Comments

Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies

Department of Clinical Laboratory, Wenling Hospital of Traditional Chinese Wenling, Zhejiang Province
Department of Clinical Laboratory, South China Hospital, Medical School, Shenzhen University, Shenzhen, 518111
Haematologica Early view Jan 30, 2025 https://doi.org/10.3324/haematol.2024.287052

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments
 
DOI
https://doi.org/10.3324/haematol.2024.287052
 
Published
2025-01-30
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
6
PDF Downloads
1

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online